Annovis Bio Stock Market Value
| ANVS Stock | USD 6.65 0.14 2.06% |
| Symbol | Annovis |
Annovis Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.22) | Return On Assets (1.55) | Return On Equity (5.97) |
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Annovis Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Annovis Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Annovis Bio.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in Annovis Bio on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding Annovis Bio or generate 0.0% return on investment in Annovis Bio over 30 days. Annovis Bio is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration More
Annovis Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Annovis Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Annovis Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 20.79 | |||
| Value At Risk | (5.58) | |||
| Potential Upside | 6.62 |
Annovis Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Annovis Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Annovis Bio's standard deviation. In reality, there are many statistical measures that can use Annovis Bio historical prices to predict the future Annovis Bio's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.51) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.50) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Annovis Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Annovis Bio Backtested Returns
Annovis Bio secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of risk over the last 3 months. Annovis Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Annovis Bio's Mean Deviation of 3.16, risk adjusted performance of (0.07), and Standard Deviation of 4.19 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.83, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Annovis Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Annovis Bio is expected to be smaller as well. At this point, Annovis Bio has a negative expected return of -0.49%. Please make sure to confirm Annovis Bio's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Annovis Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.65 |
Good predictability
Annovis Bio has good predictability. Overlapping area represents the amount of predictability between Annovis Bio time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Annovis Bio price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Annovis Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.65 | |
| Spearman Rank Test | 0.74 | |
| Residual Average | 0.0 | |
| Price Variance | 0.24 |
Annovis Bio lagged returns against current returns
Autocorrelation, which is Annovis Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Annovis Bio's stock expected returns. We can calculate the autocorrelation of Annovis Bio returns to help us make a trade decision. For example, suppose you find that Annovis Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Annovis Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Annovis Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Annovis Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Annovis Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Annovis Bio Lagged Returns
When evaluating Annovis Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Annovis Bio stock have on its future price. Annovis Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Annovis Bio autocorrelation shows the relationship between Annovis Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Annovis Bio.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.